Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Fujifilm Supports Continuing Medical Education Event To Advance Knowledge Of Digital Breast Tomosynthesis In Breast Cancer Screening, Diagnosis, And The Patient Experience | ||
By: PR Newswire Association LLC. - 12 Jun 2019 | Back to overview list |
|
LEXINGTON, Mass., June 12, 2019 /PRNewswire/ -- FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, will provide an unrestricted educational grant to host a continuing medical education (CME) program titled "Encourage Your Patient to Be Fearless" on June 12, 2019 from 5:30 – 8:00 PM at 1100 SE Waverly Drive in Portland, Oregon. A panel of thought leaders from healthcare organizations in the Portland area will cover various specialties involved in the management and care of breast cancer patients by sharing their personal and clinical experiences. Expert panelists include:
The experts will highlight the importance of clear and concise communication through-out the continuum of care. This event focuses on the impact of the adoption of Digital Breast Tomosynthesis technology and its influence on aspects of the breast screening clinical pathway. A question and answer session will follow at the end of the presentations. The CME program has been approved by The Association for Medical Imaging Management (AHRA) for one and a half (1.5) Category A, ARRT CE Credits. For more information and to register for the upcoming program, please visit: https://www.appliedradiology.org/PortlandCME/ About Fujifilm FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2019, the company had global revenues of $22 billion, at an exchange rate of 111 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com . All product and company names herein may be trademarks of their registered owners. View original content to download multimedia:http://www.prnewswire.com/news-releases/fujifilm-supports-continuing-medical-education-event-to-advance-knowledge-of-digital-breast-tomosynthesis-in-breast-cancer-screening-diagnosis-and-the-patient-experience-300866630.html SOURCE Fujifilm |
||
|
||
Copyright 2019 PR Newswire Association LLC. | Back to overview list |